Latest Insider Transactions at Health Catalyst, Inc. (HCAT)
This section provides a real-time view of insider transactions for Health Catalyst, Inc. (HCAT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Health Catalyst, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Health Catalyst, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 03
2024
|
Daniel Le Sueur Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,208
-3.25%
|
$31,248
$6.15 P/Share
|
|
Jun 17
2024
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,290
-1.05%
|
$7,740
$6.37 P/Share
|
|
Jun 13
2024
|
S. Dawn Smith |
BUY
Grant, award, or other acquisition
|
Direct |
20,807
+24.12%
|
-
|
|
Jun 13
2024
|
Anita Pramoda |
BUY
Grant, award, or other acquisition
|
Direct |
20,807
+27.78%
|
-
|
|
Jun 13
2024
|
Julie Larson Green |
BUY
Grant, award, or other acquisition
|
Direct |
20,807
+24.18%
|
-
|
|
Jun 13
2024
|
John A Kane |
BUY
Grant, award, or other acquisition
|
Direct |
20,807
+13.71%
|
-
|
|
Jun 13
2024
|
Duncan Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
20,807
+21.83%
|
-
|
|
Jun 12
2024
|
Jason Alger Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,823
-2.33%
|
$16,938
$6.83 P/Share
|
|
Jun 11
2024
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-2.74%
|
$45,000
$6.53 P/Share
|
|
Jun 06
2024
|
Daniel Le Sueur Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
11,923
-6.92%
|
$71,538
$6.72 P/Share
|
|
Jun 06
2024
|
Benjamin Landry General Counsel |
SELL
Open market or private sale
|
Direct |
2,387
-2.23%
|
$14,322
$6.71 P/Share
|
|
Jun 03
2024
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,716
-1.38%
|
$10,296
$6.53 P/Share
|
|
Jun 03
2024
|
Daniel Le Sueur Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,873
-1.08%
|
$11,238
$6.53 P/Share
|
|
Jun 03
2024
|
Benjamin Landry General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,300
-1.2%
|
$7,800
$6.53 P/Share
|
|
Jun 03
2024
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,951
-1.07%
|
$17,706
$6.53 P/Share
|
|
Jun 03
2024
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,238
-1.01%
|
$7,428
$6.53 P/Share
|
|
Jun 03
2024
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,442
-0.38%
|
$26,652
$6.53 P/Share
|
|
May 31
2024
|
Benjamin Landry General Counsel |
SELL
Open market or private sale
|
Direct |
12,577
-10.4%
|
$75,462
$6.61 P/Share
|
|
May 15
2024
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,066
-1.64%
|
$14,462
$7.0 P/Share
|
|
Apr 15
2024
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,005
-1.56%
|
$12,030
$6.11 P/Share
|
|
Mar 15
2024
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,005
-1.54%
|
$14,035
$7.8 P/Share
|
|
Mar 01
2024
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,540
-1.61%
|
$36,320
$8.05 P/Share
|
|
Mar 01
2024
|
Bryan Truman Hunt Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,684
-5.05%
|
$93,472
$8.05 P/Share
|
|
Mar 01
2024
|
Jason Alger Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+36.41%
|
-
|
|
Mar 01
2024
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,474
-4.52%
|
$19,792
$8.05 P/Share
|
|
Mar 01
2024
|
Benjamin Landry General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,315
-2.67%
|
$26,520
$8.05 P/Share
|
|
Mar 01
2024
|
Daniel Le Sueur Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+28.66%
|
-
|
|
Mar 01
2024
|
Daniel Le Sueur Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,279
-3.05%
|
$26,232
$8.05 P/Share
|
|
Mar 01
2024
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,439
-2.57%
|
$27,512
$8.05 P/Share
|
|
Mar 01
2024
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,973
-0.42%
|
$39,784
$8.05 P/Share
|
|
Feb 27
2024
|
Daniel D. Burton Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
26,200
+2.19%
|
$183,400
$7.81 P/Share
|
|
Feb 20
2024
|
Bryan Truman Hunt Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,111
+4.58%
|
-
|
|
Feb 20
2024
|
Jason Alger Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,778
+4.83%
|
-
|
|
Feb 20
2024
|
Linda Llewelyn Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
68,889
+18.1%
|
-
|
|
Feb 20
2024
|
Benjamin Landry General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
79,444
+20.98%
|
-
|
|
Feb 20
2024
|
Kevin Lee Freeman Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
113,334
+14.77%
|
-
|
|
Feb 20
2024
|
Daniel D. Burton Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+17.9%
|
-
|
|
Feb 15
2024
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
3,262
-4.79%
|
$29,358
$9.77 P/Share
|
|
Jan 16
2024
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
3,163
-4.44%
|
$31,630
$10.83 P/Share
|
|
Dec 15
2023
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
3,163
-4.25%
|
$25,304
$8.83 P/Share
|
|
Dec 06
2023
|
Jason Alger Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,177
-4.02%
|
$15,239
$7.55 P/Share
|
|
Dec 01
2023
|
Anne Marie Bickmore COO and Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,114
-6.06%
|
$28,798
$7.45 P/Share
|
|
Dec 01
2023
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,921
-1.71%
|
$20,447
$7.45 P/Share
|
|
Dec 01
2023
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,478
-0.94%
|
$59,346
$7.45 P/Share
|
|
Dec 01
2023
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,161
-5.3%
|
$29,127
$7.45 P/Share
|
|
Dec 01
2023
|
Benjamin Landry General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,427
-7.11%
|
$23,989
$7.45 P/Share
|
|
Dec 01
2023
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,838
-4.98%
|
$19,866
$7.45 P/Share
|
|
Dec 01
2023
|
Bryan Truman Hunt Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,118
-6.02%
|
$98,826
$7.45 P/Share
|
|
Nov 15
2023
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,196
-1.5%
|
$9,568
$8.25 P/Share
|
|
Oct 16
2023
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,161
-1.44%
|
$9,288
$8.33 P/Share
|